The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Hypertension, Pulmonary

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Hypertension, Pulmonary


Psychiatry related information on Hypertension, Pulmonary


High impact information on Hypertension, Pulmonary


Chemical compound and disease context of Hypertension, Pulmonary


Biological context of Hypertension, Pulmonary


Anatomical context of Hypertension, Pulmonary


Gene context of Hypertension, Pulmonary


Analytical, diagnostic and therapeutic context of Hypertension, Pulmonary


Chemical compound and disease context of Hypertension, Pulmonary


  1. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. Trembath, R.C., Thomson, J.R., Machado, R.D., Morgan, N.V., Atkinson, C., Winship, I., Simonneau, G., Galie, N., Loyd, J.E., Humbert, M., Nichols, W.C., Morrell, N.W., Berg, J., Manes, A., McGaughran, J., Pauciulo, M., Wheeler, L. N. Engl. J. Med. (2001) [Pubmed]
  2. Atrial natriuretic peptide attenuates the development of pulmonary hypertension in rats adapted to chronic hypoxia. Jin, H., Yang, R.H., Chen, Y.F., Jackson, R.M., Oparil, S. J. Clin. Invest. (1990) [Pubmed]
  3. Acetyl glyceryl ether phosphorylcholine-stimulated human platelets cause pulmonary hypertension and edema in isolated rabbit lungs. Role of thromboxane A2. Heffner, J.E., Shoemaker, S.A., Canham, E.M., Patel, M., McMurtry, I.F., Morris, H.G., Repine, J.E. J. Clin. Invest. (1983) [Pubmed]
  4. Sildenafil for lung fibrosis and pulmonary hypertension. Kleinsasser, A., Loeckinger, A. Lancet (2003) [Pubmed]
  5. Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. Abramson, S.V., Burke, J.F., Kelly, J.J., Kitchen, J.G., Dougherty, M.J., Yih, D.F., McGeehin, F.C., Shuck, J.W., Phiambolis, T.P. Ann. Intern. Med. (1992) [Pubmed]
  6. HIV-1 TAT represses transcription of the bone morphogenic protein receptor-2 in U937 monocytic cells. Caldwell, R.L., Gadipatti, R., Lane, K.B., Shepherd, V.L. J. Leukoc. Biol. (2006) [Pubmed]
  7. Hemodynamic and exercise effects of phosphodiesterase 5 inhibitors. Jackson, G. Am. J. Cardiol. (2005) [Pubmed]
  8. Neonatal pulmonary hypertension--urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function. Pearson, D.L., Dawling, S., Walsh, W.F., Haines, J.L., Christman, B.W., Bazyk, A., Scott, N., Summar, M.L. N. Engl. J. Med. (2001) [Pubmed]
  9. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue. Hoeper, M.M., Schwarze, M., Ehlerding, S., Adler-Schuermeyer, A., Spiekerkoetter, E., Niedermeyer, J., Hamm, M., Fabel, H. N. Engl. J. Med. (2000) [Pubmed]
  10. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. Clark, R.H., Kueser, T.J., Walker, M.W., Southgate, W.M., Huckaby, J.L., Perez, J.A., Roy, B.J., Keszler, M., Kinsella, J.P. N. Engl. J. Med. (2000) [Pubmed]
  11. Fatal pulmonary hypertension associated with short-term use of fenfluramine and phentermine. Mark, E.J., Patalas, E.D., Chang, H.T., Evans, R.J., Kessler, S.C. N. Engl. J. Med. (1997) [Pubmed]
  12. Endothelin-1 in pulmonary hypertension. Cacoub, P., Dorent, R., Nataf, P., Carayon, A. N. Engl. J. Med. (1993) [Pubmed]
  13. Thromboxane and prostacyclin metabolites in pulmonary hypertension. Cacoub, P., Dorent, R., Carayon, A. N. Engl. J. Med. (1992) [Pubmed]
  14. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. Christman, B.W., McPherson, C.D., Newman, J.H., King, G.A., Bernard, G.R., Groves, B.M., Loyd, J.E. N. Engl. J. Med. (1992) [Pubmed]
  15. Isoproterenol in pulmonary hypertension. Pelman, M.J., Tiep, B.L., Westinghouse, W.D. N. Engl. J. Med. (1978) [Pubmed]
  16. Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor. Cowan, K.N., Heilbut, A., Humpl, T., Lam, C., Ito, S., Rabinovitch, M. Nat. Med. (2000) [Pubmed]
  17. Inhaled nebulized nitrite is a hypoxia-sensitive NO-dependent selective pulmonary vasodilator. Hunter, C.J., Dejam, A., Blood, A.B., Shields, H., Kim-Shapiro, D.B., Machado, R.F., Tarekegn, S., Mulla, N., Hopper, A.O., Schechter, A.N., Power, G.G., Gladwin, M.T. Nat. Med. (2004) [Pubmed]
  18. Persistence of the fetal pattern of tropoelastin gene expression in severe neonatal bovine pulmonary hypertension. Stenmark, K.R., Durmowicz, A.G., Roby, J.D., Mecham, R.P., Parks, W.C. J. Clin. Invest. (1994) [Pubmed]
  19. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial. Ghofrani, H.A., Wiedemann, R., Rose, F., Schermuly, R.T., Olschewski, H., Weissmann, N., Gunther, A., Walmrath, D., Seeger, W., Grimminger, F. Lancet (2002) [Pubmed]
  20. Endothelin system: the double-edged sword in health and disease. Kedzierski, R.M., Yanagisawa, M. Annu. Rev. Pharmacol. Toxicol. (2001) [Pubmed]
  21. The effect of low-dose intravenous nitroglycerin on pulmonary hypertension immediately after replacement of a stenotic mitral valve. Ziskind, Z., Pohoryles, L., Mohr, R., Smolinsky, A., Quang, H.T., Ruvolo, G., Goor, D.A. Circulation (1985) [Pubmed]
  22. Thallium 201 myocardial imaging in patients with pulmonary hypertension. Cohen, H.A., Baird, M.G., Rouleau, J.R., Fuhrmann, C.F., Bailey, I.K., Summer, W.R., Strauss, H.W., Pitt, B. Circulation (1976) [Pubmed]
  23. Evidence for the association of unexplained pulmonary hypertension in children with the major histocompatibility complex. Barst, R.J., Flaster, E.R., Menon, A., Fotino, M., Morse, J.H. Circulation (1992) [Pubmed]
  24. Enhanced expression of transient receptor potential channels in idiopathic pulmonary arterial hypertension. Yu, Y., Fantozzi, I., Remillard, C.V., Landsberg, J.W., Kunichika, N., Platoshyn, O., Tigno, D.D., Thistlethwaite, P.A., Rubin, L.J., Yuan, J.X. Proc. Natl. Acad. Sci. U.S.A. (2004) [Pubmed]
  25. Endothelin receptor antagonists in a beagle model of pulmonary hypertension: contribution to possible potential therapy? Okada, M., Yamashita, C., Okada, M., Okada, K. J. Am. Coll. Cardiol. (1995) [Pubmed]
  26. Autocrine function of inducible nitric oxide synthase and cyclooxygenase-2 in proliferation of human and rat pulmonary artery smooth-muscle cells: species variation. Jourdan, K.B., Evans, T.W., Lamb, N.J., Goldstraw, P., Mitchell, J.A. Am. J. Respir. Cell Mol. Biol. (1999) [Pubmed]
  27. Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline. Voelkel, N.F., Tuder, R.M., Bridges, J., Arend, W.P. Am. J. Respir. Cell Mol. Biol. (1994) [Pubmed]
  28. PDGF signaling in pulmonary arterial hypertension. Barst, R.J. J. Clin. Invest. (2005) [Pubmed]
  29. Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: a case series. McLaughlin, V.V., Genthner, D.E., Panella, M.M., Hess, D.M., Rich, S. Ann. Intern. Med. (1999) [Pubmed]
  30. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Stewart, D.J., Levy, R.D., Cernacek, P., Langleben, D. Ann. Intern. Med. (1991) [Pubmed]
  31. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Wessel, D.L., Adatia, I., Giglia, T.M., Thompson, J.E., Kulik, T.J. Circulation (1993) [Pubmed]
  32. Autoantibodies against B23, a nucleolar phosphoprotein, occur in scleroderma and are associated with pulmonary hypertension. Ulanet, D.B., Wigley, F.M., Gelber, A.C., Rosen, A. Arthritis Rheum. (2003) [Pubmed]
  33. NT-proBNP reflects right ventricular structure and function in pulmonary hypertension. Gan, C.T., McCann, G.P., Marcus, J.T., van Wolferen, S.A., Twisk, J.W., Boonstra, A., Postmus, P.E., Vonk-Noordegraaf, A. Eur. Respir. J. (2006) [Pubmed]
WikiGenes - Universities